GM-CSF-based myeloma cellular vaccine (allogeneic)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GM-CSF-based myeloma cellular vaccine (allogeneic), covering 2019-10-08 to 2019-10-08. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma [Phase 2]